To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease

NCT02601560 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

BIOLOGICAL: MEDI6012
BIOLOGICAL: Placebo SC
BIOLOGICAL: Placebo IV

Sponsor

MedImmune LLC